Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small molecule potassium competitive acid blocker medicine that ... Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection. Mostra di più
| Periodo † | Var | Var % | Apert. | Max | Min | Med. Vol. Giorn. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.73 | -15.4334038055 | 4.73 | 4.8 | 3.87 | 1123329 | 4.03421254 | CS |
| 4 | -2.38 | -37.3040752351 | 6.38 | 6.89 | 3.81 | 1257986 | 5.01842833 | CS |
| 12 | -2.28 | -36.3057324841 | 6.28 | 6.98 | 3.81 | 1209590 | 5.39163508 | CS |
| 26 | -12.56 | -75.845410628 | 16.56 | 19.5 | 3.81 | 1241505 | 7.91220601 | CS |
| 52 | -5.01 | -55.6048834628 | 9.01 | 19.675 | 3.81 | 1009025 | 10.23947352 | CS |
| 156 | -9.43 | -70.2159344751 | 13.43 | 19.675 | 3.81 | 617351 | 9.9942072 | CS |
| 260 | -30.09 | -88.2663537694 | 34.09 | 64.54 | 3.81 | 410763 | 12.24268624 | CS |
| Nessuna Discussione Trovata |
| Crea Discussione |
Le azioni che visualizzerai appariranno in questo riquadro, così potrai facilmente tornare alle quotazioni di tuo interesse.
Assistenza: support@advfn.it
Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni
Caratteristiche principali
Premium
